ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01496170
Recruitment Status : Completed
First Posted : December 21, 2011
Last Update Posted : October 23, 2015
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.